Exploro Male Fertility and Sperm Concentration Tests Recalled Due to Lack of FDA Clearance
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Changchun Wancheng Bio-Electron Co., Ltd. is recalling 4,800 Exploro male fertility test kits because they were distributed without required legal marketing clearance.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-device.
What Happened
Changchun Wancheng Bio-Electron Co., Ltd. has initiated a voluntary recall of its Exploro Highly Sensitive Male Fertility / Sperm Concentration Tests. The recall was triggered because the test strips and diagnostic components were distributed to U.S. customers before obtaining the necessary 510(k) clearance required for legal marketing. According to the FDA, these unvetted devices may produce false or inaccurate diagnostic results when used by consumers, which could lead to inappropriate medical interventions.
Which Products Are Affected
The recall involves approximately 4,800 units of the Exploro Highly Sensitive Male Fertility / Sperm Concentration Test. The affected products were distributed nationwide, with specific distribution confirmed in Texas, Georgia, and California.
The following lot numbers and expiration dates are included in this recall:
- Lot 2025033101: Expiration 03-30-2027
- Lot 2025080801: Expiration 08-07-2027
- Lot 2025090844: Expiration 09-07-2027
What You Should Do
Consumers who possess the affected test kits should stop using them immediately. The manufacturer began notifying customers of the issue via letter on November 22, 2025. Users who have already performed tests using these kits should consult with a healthcare professional to verify results using FDA-cleared diagnostic tools. For information regarding returns or refunds, consumers should contact Changchun Wancheng Bio-Electron Co., Ltd. at their headquarters in Changchun, China, or reach out to the original point of purchase.
Why This Matters
Diagnostic tests that have not undergone the required FDA review process pose a safety risk because their accuracy cannot be guaranteed. Inaccurate fertility results may cause significant emotional distress or lead individuals to pursue unnecessary or incorrect medical treatments.
Source
Information provided by the FDA under recall number Z-1263-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.